Jonas Schwan
YOU?
Author Swipe
View article: Monitoring Nanostructural Dynamics During the Electrochemical Growth of Metal Hydroxide Thin Films by <i>in‐situ</i> Small‐Angle X‐Ray Scattering
Monitoring Nanostructural Dynamics During the Electrochemical Growth of Metal Hydroxide Thin Films by <i>in‐situ</i> Small‐Angle X‐Ray Scattering Open
Understanding structural dynamics on the nanoscale is essential for progress in current research areas such as catalysis, energy storage, and nanotechnology. In this study, we introduce an in‐house electrochemical flow cell for real‐time s…
View article: Comparing the Colloidal Stabilities of Commercial and Biogenic Iron Oxide Nanoparticles That Have Potential In Vitro/In Vivo Applications
Comparing the Colloidal Stabilities of Commercial and Biogenic Iron Oxide Nanoparticles That Have Potential In Vitro/In Vivo Applications Open
For the potential in vitro/in vivo applications of magnetic iron oxide nanoparticles, their stability in different physiological fluids has to be ensured. This important prerequisite includes the preservation of the particles’ stability du…
View article: Strain-Induced Self-Rolling of Electrochemically Deposited Co(OH)2 Films into Organic–Inorganic Microscrolls
Strain-Induced Self-Rolling of Electrochemically Deposited Co(OH)2 Films into Organic–Inorganic Microscrolls Open
Strain-induced self-folding is a ubiquitous phenomenon in biology, but is rarely seen in brittle geological or synthetic inorganic materials. We here apply this concept for the preparation of three-dimensional free-standing microscrolls of…
View article: Muscle LIM Protein Force-Sensing Mediates Sarcomeric Biomechanical Signaling in Human Familial Hypertrophic Cardiomyopathy
Muscle LIM Protein Force-Sensing Mediates Sarcomeric Biomechanical Signaling in Human Familial Hypertrophic Cardiomyopathy Open
Background: Familial hypertrophic cardiomyopathy (HCM) is the most common inherited cardiac disease and is typically caused by mutations in genes encoding sarcomeric proteins that regulate cardiac contractility. HCM manifestations include …
View article: Loss of crossbridge inhibition drives pathological cardiac hypertrophy in patients harboring the TPM1 E192K mutation
Loss of crossbridge inhibition drives pathological cardiac hypertrophy in patients harboring the TPM1 E192K mutation Open
Hypertrophic cardiomyopathy (HCM) is an inherited disorder caused primarily by mutations to thick and thinfilament proteins. Although thin filament mutations are less prevalent than their oft-studied thick filament counterparts, they are f…
View article: Extracellular Matrix From Hypertrophic Myocardium Provokes Impaired Twitch Dynamics in Healthy Cardiomyocytes
Extracellular Matrix From Hypertrophic Myocardium Provokes Impaired Twitch Dynamics in Healthy Cardiomyocytes Open
Hypertrophic cardiomyopathy (HCM) is often caused by single sarcomeric gene mutations that affect muscle contraction. Pharmacological correction of mutation effects prevents but does not reverse disease in mouse models. Suspecting that dis…